Corporate

Berlin Pharmaceutical and Acino Pharma Sign Partnership in Thailand

Berlin Pharmaceutical Industry Co., Ltd. and Acino Pharma signed a long term partnership agreement under which Berlin will market a wide range of the Swiss company’s products in Thailand

Published

10 years ago

September 5, 2011

Akanksha Singh

Berlin Pharmaceutical Industry Co., Ltd. and Acino Pharma AG (SIX: ACIN) signed a long term partnership agreement under which Berlin will market a wide range of the Swiss company’s current and future products in Thailand.

“The new products will complement our current line of therapies as well as significantly expand our presence into new areas,” said Amal Naj, Chief Executive Officer of Berlin. “We are very excited about this association with Acino and the high quality products we will bring to our patients at affordable prices,” he said.

Peter Burema, CEO of Acino Group

Peter Burema, CEO of Acino Group, said,

“We are very pleased to partner with one of the leading pharmaceutical companies in Thailand to introduce our products in the market. We see great opportunities for our products there and rest of Asia and other emerging markets.”

Acino, based in Basle, Switzerland, specializes in the development, registration and manufacture of generic and innovative pharmaceuticals using advanced drug delivery technologies, for which it also holds patents. With a focus on solid oral dosage forms with modified release of the active ingredient, transdermal therapeutic patches and biodegradable, subcutaneous implants, Acino supplies leading pharmaceutical companies throughout Europe

Mr. Naj said the vast majority of the Acino products Berlin will introduce in Thailand are for the treatment of urological disorders, cancer and pain. The company’s current products are prescribed mainly for the treatment of cardiovascular and metabolic diseases and gastro-intestinal disorders.

Mr. Naj said a number of Acino products are innovative, and they will help strengthen Berlin’s market presence in the highly competitive market.

Berlin currently manufactures most of its products in GMP-approved (Good Manufacturing Practice) and ISO-certified facilities, and imports active pharmaceutical ingredients (API) as well as finished products from Canada, France, and India.

Berlin is one of the top 10 pharmaceutical companies in Thailand and is a market leader in many of the products it markets. The company employs 550 people.

The Acino Group is headquartered in Basle, and currently employs approximately 380 staff. Acino Holding Ltd., the Group’s parent, is listed on the SIX Swiss Exchange (SIX: ACIN).

Please note that under Thai FDA regulation, we cannot discuss individual products.

CONTACT

Pajasalmi, Ruangkittikul & Associates Ltd.

Khun Panarasee Thaiwatcharamas

Khun Komson Kaemthong

+662 651 8989 Ext. 222 and 441

Berlin Pharmaceutical Industry

Amal Naj, CEO

+662 652 9590

[email protected]

Acino Pharma AG

Peter Burema, CEO

+41 61 338 60 00

[email protected]

www.acino-pharma.com

SOURCE Berlin Pharmaceutical Industry

Corporate

The 3 key barriers to remote working (and how to overcome them)

COVID-19 created the world’s largest remote working experiment and, for many, showed just how possible it was for employees to do their jobs without being at the office.

Published

4 weeks ago

March 26, 2021

Daniel Lorenzzo

Following the real-world experiment with remote working, it’s time for business leaders to re-examine their previous misgivings, and explore how to adopt flexible working in the long term

(more…)

Corporate

Digital transformation: what will be the long‑term effect of Covid‑19?

For many businesses, the Covid-19 pandemic was the catalyst for their organisational caterpillar to evolve toward digital transformation. Yet following the crisis, it remains to be seen which companies will emerge with wings – and which will simply be crawling along slightly faster than before.

Published

4 weeks ago

March 23, 2021

Daniel Lorenzzo

The outbreak of Covid-19 forced the rapid adoption of remote working practices and an acknowledgment of the importance of digital transformation. Following the pandemic, what will the lasting impact be?

(more…)

Corporate

Fitch Ratings Expects Improvement of Thai Corporates’ Credit Outlook

Fitch said the outlook for the food retail sector in 2021 would remain stable as earnings rebound, while the outlook for the building material and power & utilities sectors to be stable in the coming years.

Published

4 weeks ago

March 22, 2021

National News Bureau of Thailand

BANGKOK (NNT) – The credit rating agency Fitch Ratings expects Thai corporates’ credit outlook to improve this year as vaccination is rolled out and economic activity recovers.

(more…)